P/E ratio for ResMed (RMD)
P/E ratio as of April 2025 (TTM): 35.0
According to ResMed's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 35.0016. At the end of 2022 the company had a P/E ratio of 37.7.
P/E ratio history for ResMed from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 37.7 | -48.18% |
| 2021 | 72.8 | 65.33% |
| 2020 | 44.0 | -9.98% |
| 2019 | 48.9 | 35.24% |
| 2018 | 36.1 | -13.78% |
| 2017 | 41.9 | 55.41% |
| 2016 | 27.0 | 25.12% |
| 2015 | 21.6 | -3.84% |
| 2014 | 22.4 | 8.6% |
| 2013 | 20.6 | 0.84% |
| 2012 | 20.5 | 82.2% |
| 2011 | 11.2 | -53.77% |
| 2010 | 24.3 | 6.96% |
| 2009 | 22.7 | -3.59% |
| 2008 | 23.6 | -63.65% |
| 2007 | 64.9 | 81.83% |
| 2006 | 35.7 | -5.04% |
| 2005 | 37.6 | 36.71% |
| 2004 | 27.5 | 2.51% |
| 2003 | 26.8 | 6.95% |
| 2002 | 25.1 | -78.16% |
| 2001 | 115 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 | 30.8 | -11.92% | 🇮🇪 Ireland |
 | 29.3 | -16.38% | 🇺🇸 USA |
 | 73.9 | 111.22% | 🇺🇸 USA |
 | -0.0042 | -100.01% | 🇺🇸 USA |
 | -1.70 | -104.87% | 🇺🇸 USA |
 | -32.3 | -192.24% | 🇳🇱 Netherlands |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.